300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Mexico
Nigeria
Liberia
Malawi
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Madagascar
Pakistan
Poland
Lesotho
Romania
Oman
Puerto Rico
China
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Jamaica
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
Latvia
El Salvador
Mali
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Bangladesh
Barbados
Belgium
Spain
Angola
Europe
Cyprus
Austria
Ethiopia
Azerbaijan
Jordan
Bulgaria
Estonia
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Bahamas
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Lebanon
Mongolia
Honduras
Iceland
Cambodia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Finchley Healthcare Ventures, VC Fund

Finchley Healthcare Ventures

VC Fund

Finchley Healthcare Ventures is an investment firm invest in venture capital funds specializing in life sciences, leveraging their expertise and network to access a diverse range of investment opportunities.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries Finchley Healthcare Ventures invests in

BiotechnologyBiopharmaLife ScienceAnalyticsHealth Care

Stages Finchley Healthcare Ventures invests in

Series BSeries A

Countries Finchley Healthcare Ventures invests in

United StatesBelgium

Round sizes

Series B $67M–$120M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series B
$67M–$120M

Investment Focus

Industry

  • Biotechnology 3 (75%)
  • Biopharma 2 (50%)
  • Life Science 2 (50%)
  • Analytics 1 (25%)
  • Health Care 1 (25%)
See all 8 industries →

Stage

  • Series B 2 (50%)
  • Series A 1 (25%)

Country

  • United States 2 (50%)
  • Belgium 1 (25%)

Team

NameTitleInvestmentsLinksEmail
David Goodman
David Goodman Founder
Founder Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.Coultreon Biopharma employs extensive experience in disease biology, drug development, and translational science to identify the optimum treatment approach for addressing underlying illness biology withbest-in-class therapeutics. $125M / Series A / Apr 28, 2026
Triana Biomedicines Triana Biomedicines
Triana Biomedicines is building the leading molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high- resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas. $120M / Series B / Dec 03, 2025
Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets. $67M / Series B / Oct 02, 2025
Reverb Therapeutics engages in the development of treatments for cancer and other diseases. $12M / Seed / Feb 19, 2025

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Mexico
Nigeria
Liberia
Malawi
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Madagascar
Pakistan
Poland
Lesotho
Romania
Oman
Puerto Rico
China
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Jamaica
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Canada
Ireland
South Africa
France
Georgia
Denmark
Ghana
Iraq
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
Latvia
El Salvador
Mali
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Argentina
Bangladesh
Barbados
Belgium
Spain
Angola
Europe
Cyprus
Austria
Ethiopia
Azerbaijan
Jordan
Bulgaria
Estonia
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Belize
Bahamas
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Lebanon
Mongolia
Honduras
Iceland
Cambodia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Finchley Healthcare Ventures invest in?

Finchley Healthcare Ventures invests primarily in Biotechnology, Biopharma and Life Science startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Finchley Healthcare Ventures's check size?

Finchley Healthcare Ventures typically joins rounds of $67M–$120M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Finchley Healthcare Ventures participates in.

How do I contact Finchley Healthcare Ventures?

Public channels for Finchley Healthcare Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Finchley Healthcare Ventures?

The team at Finchley Healthcare Ventures includes David Goodman (Founder). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Finchley Healthcare Ventures Finchley Healthcare Ventures Find emails